Navigation Links
Neuralstem's ALS Trial on Clinical Hold
Date:2/20/2009

ROCKVILLE, Md., Feb. 20 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) announced today its spinal cord stem cell trial to treat ALS is on clinical hold and that the Federal Drug Administration (FDA) has provided the Company with specific comments, questions and recommendations for modifications to its protocol.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO )

"The FDA has presented us with their review of our entire Investigational New Drug (IND) application," said Richard Garr, Neuralstem's President & CEO. "They have asked for some additional information regarding our product manufacturing process and pre-clinical studies, as well as our novel clinical delivery injection device and technique. The Company believes that it can provide this information in an expeditious manner."

"The Agency has also requested various modifications to the protocol and eligibility criteria for patients in the trial, as well as slight changes to the timing of the surgeries," Mr. Garr continued. "We are evaluating these changes and will respond accordingly. The Agency had extensive 'non hold' comments, requests for information, and recommendations. These primarily concerned issues that will need to be addressed for final product manufacturing and testing. We are appreciative of their work in this area."

"Over all we believe the Agency's comments and recommendations are extremely helpful," Garr concluded. "We are evaluating them carefully, and expect to reach agreement with the Agency on all matters so that the trial can be approved and move forward."

About Neuralstem

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to contro
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015  Membership in Medicare Supplement plans ... Healthcare Business Strategy report released by Mark Farrah ... Medigap or Med Supp plans, covered approximately 11.2 ... 5.2% increase from 2013. Between 2013 and 2014, ... covered lives.  Though UnitedHealth was the segment growth ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has announced ... Global Strategic Business Report" report to their offering. ... Canada , Japan , ... and Rest of World. Annual estimates and forecasts are provided ... analysis is provided for these markets. The global ...
(Date:5/6/2015)...   CEFALY Technology , the creators of the ... for use prior to the onset of migraine pain, ... at the EUROHEADPAIN - Midterm Meeting at the International ... , from May 14-17, 2015. On May ... major European research project focused on migraines, CEFALY ...
Breaking Medicine Technology:Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2
... LOUIS, Oct. 25, 2011 Stereotaxis, Inc. (NASDAQ: ... results for the third quarter ended September 30, 2011 on ... financial markets.  The Company will host a conference call and ... Time to discuss the Company,s third quarter results and corporate ...
... some newly-developed bio-pharmaceutical products thrive upon launch, many more ... In order to differentiate the treatment benefits of ... and scientific thought leaders, targeting and engaging those who ... in the medical community. In fact, according ...
Cached Medicine Technology:Stereotaxis to Report Third Quarter 2011 Financial Results and Conduct Conference Call on November 7, 2011 2Stereotaxis to Report Third Quarter 2011 Financial Results and Conduct Conference Call on November 7, 2011 3Latest Pharmaceutical Launch Strategies Demonstrate Growing Importance of Thought Leader Engagement at Market Entry 2
(Date:5/6/2015)... (PRWEB) May 06, 2015 Anitha Nallari, ... Hematology Oncology Consultants, Inc. in Columbus, OH. Dr. ... has a special focus in breast cancer, lung cancer, GI ... lymphoma as well as benign hematology. , Dr. ... internal medicine by the American Board of Internal Medicine. She ...
(Date:5/6/2015)... May 06, 2015 Vancouver Chiropractic ... shared their new blog containing the Canadian Physical ... the Canadian Society for Exercise Physiology (CSEP). Since ... activity, health and fitness research and personal training ... exercise are highly beneficial and a rich resource ...
(Date:5/6/2015)... May 06, 2015 Follow us ... are increasing, driven by the rising consumer awareness over ... of contagious diseases. Hand washing is becoming a part ... apprehension over contracting infections. Periodic outbreak of Avian flu, ... Ebola virus disease (EVD) epidemic in West ...
(Date:5/6/2015)... HOUSTON, TX (PRWEB) May 06, 2015 ... the 1,000 user mark after launching in mid-February. The ... qualified candidates who have previous experience in the industry. ... their profession. , According to Kyle Johnson, CTO, unique ... compared to the first month: "Each new job posting ...
(Date:5/6/2015)... TU-Automotive has opened press registration for TU-Automotive Detroit as ... the headlines of major publications world-wide. With 150+ speakers ... ready to share their visions for the future of ... press to go behind the scenes and hear major ... “This year we’re releasing a preview of all the ...
Breaking Medicine News(10 mins):Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 4Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:Press Registration for TU-Automotive Detroit Now Open 2
... by researchers at the Johns Hopkins Bloomberg School of ... tactics to ward off bacterial// pathogens and plasmodium parasites. ... with the proteins in the immune system of mosquitoes. ... involved in limiting infection by the malaria parasites were ...
... conducted by the researchers at the University of Michigan ... in increased stress among adults. // Disaster such as ... 30-40 % of post-traumatic stress disorder among adults. In ... percent of the general population may experience PTSD symptoms, ...
... for implementation of supplementary nutrition scheme by training the Self ... anganwadis from the NGOs in the national capital. ... C K Thakker vacated its May 12 order by which ... to the apex court order that no contractors would be ...
... Justifying the proposed 27 per cent OBC quota in ... said that the anti-reservation agitation was a media creation ... accordance with the Constitution. ,'The resistance was ... ,Stating that all political parties had supported the government ...
... to suffer from cancer and die from it, researchers say. ... //Haifa University suspect that cancers are most likely caused by ... ,The researchers looked at the incidence and death rate ... - comparing those who emigrated from Europe before 1939 with ...
... to reattach the foot of a four-year-old boy. The boy had ... // riding over him on a lawn mover. ,According ... lawn mower when the boy came up unexpectedly behind him. Constable ... reverse and accidentally ran over the boy's leg. It was explained ...
Cached Medicine News:Health News:What Ticks the Mosquito immune system? 2Health News:PTST Mostly Seen Among Disaster Victims 2
Height-Adjustable Mobile X-ray Barrier lets you get close to your patient during special procedures like cardiac cath. 24"H x 36"W viewing panel shields the upper body of one or two people and swivel...
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre...
Wrap-Around, Full Protection Apron with BACK SUPPORT...
All Day Comfort for the Lower Body...
Medicine Products: